Company Filing History:
2 out of 5,094 
1 out of 34 
1 out of 4 Years Active: 2012-2021
Title: The Innovative Contributions of Patrick Mehlen
Introduction
Patrick Mehlen is a notable inventor based in Serezin du Rhone, France. He has made significant contributions to the field of cancer research and neurodegenerative disorders through his innovative inventions. With a total of two patents to his name, Mehlen's work focuses on the interaction of specific compounds with biological receptors, which has implications for cancer treatment and understanding neurodegenerative diseases.
Latest Patents
Mehlen's latest patents include groundbreaking methods for screening anti-cancer compounds and compositions for suppressing amyloid plaque formation. The first patent, titled "Screening for anti-cancer compounds using netrin-1 activity," describes an in vitro method for identifying anti-cancer compounds based on their ability to interact with the netrin-1 receptor. This invention also provides a method for predicting the presence of aggressive cancer types and assessing the effectiveness of anti-cancer treatments by measuring netrin-1 expression levels. The second patent, "Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disorders," outlines methods for reducing beta-amyloid peptide production and amyloid plaque formation through the administration of netrin-1 polypeptides or therapeutics.
Career Highlights
Throughout his career, Patrick Mehlen has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Centre Léon Bérard. His research has contributed to a deeper understanding of cancer biology and potential therapeutic approaches. His innovative work has positioned him as a key figure in the scientific community, particularly in the areas of oncology and neurodegenerative research.
Collaborations
Mehlen has collaborated with notable colleagues, including Agnes Bernet and Julien Fitamant. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.
Conclusion
Patrick Mehlen's contributions to science through his patents and research collaborations highlight his commitment to advancing medical knowledge and treatment options. His work continues to inspire future innovations in the fields of cancer and neurodegenerative disorders.